Drug
QLC5508
QLC5508 is a pharmaceutical drug with 4 clinical trials. Currently 3 active trials ongoing.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Active Trials
3(75%)
Phase Distribution
Ph phase_1
2
50%
Ph phase_3
2
50%
Phase Distribution
2
Early Stage
0
Mid Stage
2
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
2(50.0%)
Phase 3Large-scale testing
2(50.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
3
trials recruiting
Total Trials
4
all time
Status Distribution
Active(4)
Detailed Status
Recruiting3
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
3
Success Rate
N/A
Most Advanced
Phase 3
Trials by Phase
Phase 12 (50.0%)
Phase 32 (50.0%)
Trials by Status
recruiting375%
not_yet_recruiting125%
Recent Activity
3 active trials
Showing 4 of 4
not_yet_recruitingphase_3
QLC5508 in Participants With Metastatic Prostate Cancer
NCT07632690
recruitingphase_1
A Clinical Study of QLC5508 and/or QLH12016 in Combination With Other Anti-tumor Therapies in Subjects With Advanced Prostate Cancer
NCT07198633
recruitingphase_3
QLC5508 vs. Chemotherapy in Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma
NCT07463573
recruitingphase_1
A Study of QLC5508 Combinations in Patients With Advanced Solid Tumors
NCT07256782
Clinical Trials (4)
Showing 4 of 4 trials
NCT07632690Phase 3
QLC5508 in Participants With Metastatic Prostate Cancer
NCT07198633Phase 1
A Clinical Study of QLC5508 and/or QLH12016 in Combination With Other Anti-tumor Therapies in Subjects With Advanced Prostate Cancer
NCT07463573Phase 3
QLC5508 vs. Chemotherapy in Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma
NCT07256782Phase 1
A Study of QLC5508 Combinations in Patients With Advanced Solid Tumors
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4